NCT00887510View on ClinicalTrials.gov

Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study)

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Hypertension
Interventions
DRUG

Hydrochlorothiazide

"25 mg tablet once daily for 6 weeks~Other Names:~HCTZ"

DRUG

Trandolapril

4 mg tablet once daily for 6 weeks

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Florida

OTHER

NCT00887510 - Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study) | Biotech Hunter | Biotech Hunter